{
  "id": "ic-h2",
  "version": "1",
  "drug": {
    "slug": "oral-contraceptives",
    "display": "Oral contraceptives (combined pill)"
  },
  "supplement": {
    "slug": "berberine",
    "display": "Berberine"
  },
  "severity": "caution",
  "evidenceTier": "mechanistic",
  "mechanism": "Berberine inhibits CYP3A4 in vitro, the enzyme that clears ethinyl estradiol. The measured clinical anchor is transplant medicine (cyclosporine exposure up 34.5 percent); no contraceptive-specific human data exist. The concern is a plausible direction of changed exposure, not a measured effect.",
  "patientNotes": [
    "No measured effect of berberine on the pill exists; if you take both, a pharmacist conversation before stacking is the reasonable step.",
    "If your prescriber approves berberine on top of a GLP-1 medication, bring the pill into the same conversation."
  ],
  "pmids": [
    "42653808"
  ],
  "pubmedUrls": [
    "https://pubmed.ncbi.nlm.nih.gov/42653808/"
  ],
  "guideSlugs": [
    "semaglutide-birth-control",
    "berberine-vs-ozempic"
  ],
  "guideUrls": [
    "https://supplementbrief.com/semaglutide-birth-control/",
    "https://supplementbrief.com/berberine-vs-ozempic/"
  ],
  "pairUrl": "https://supplementbrief.com/interactions/oral-contraceptives/berberine/",
  "reviewedBy": "natallia-kalistratava",
  "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
  "lastVerified": "2026-09-19",
  "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-h2.json",
  "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-h2/"
}
